Genomenon
company
About
Genomenon develops software tools to rapidly and autonomously prioritize data points for decision-making.
- 11 - 50
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $1.70M
- Industries
- Developer Tools,Enterprise Software,Genetics,Medical,Software
- Founded date
- Jan 1, 2014
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Genomenon develops software tools to rapidly and autonomously prioritize data points for decision-making. It revolutionizes the way genetic diagnoses and discoveries are made. The company’s suite of diagnostic and discovery tools enable physicians, pharma, and researchers to quickly and accurately identify disease-causing variants from genomic-sequencing datasets.It was founded in 2014 and is headquartered in Ann Arbor, Michigan.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
$23.20M
Genomenon has raised a total of
$23.20M
in funding over 2 rounds. Their latest funding was raised on
Mar 8, 2022 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 8, 2022 | Series B | $20M | 1 | — | — | Detail |
| Feb 15, 2022 | Grant | $1.70M | 1 |
National Institutes of Health
|
— | Detail |
| Apr 25, 2017 | Grant | $1.50M | 1 |
National Institutes of Health
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
2
Genomenon is funded by 2 investors.
National Institutes of Health
and Attain Specialty Insurance Company
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Institutes of Health
|
Yes | Grant |
|
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
